InvestorsHub Logo
Followers 45
Posts 2387
Boards Moderated 0
Alias Born 08/09/2016

Re: None

Wednesday, 05/19/2021 2:36:38 PM

Wednesday, May 19, 2021 2:36:38 PM

Post# of 700302
Why patience regarding TLD is justified:
Delays in TLD could be due either to management incompetence or valid reasons (unknown to us). Is LP deciding on her own to delay TLD for months? Of course not. She has said and anyone who has worked with pharma would know that as a non-expert, she is relying on her scientific advisory board (SAB) to make recommendations on how best to proceed. This SAB has a number of world-renowned experts whom we know want to see DCVAX approved for use in their GBM patients. The advice they give LP will be based without any doubt on what these experts believe will lead to maximum likelihood of approval. Are LP's interests also aligned with the SAB (and investors)? Certainly. She has a personal interest in curing GMB (family experience) AND stands to make tens of millions of dollars if DCVAX is approved. Clearly, she also wants to maximize chances of approval, just like SAB members. We as investors want the same thing. So, even though TLD taking this long makes little sense to us on the outside, the insiders are clearly advising a long and careful process as the best means of insuring approval. Despite a bad history of communicating with investors, I think we have every reason to trust the company (and the SAB experts) to arrive at and and disclose TLD in a way that is in the best interests of all of us. The waiting is the hardest part...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News